Hongjing Zang
Papers
1
Total Citations
7
H-Index
1
About
Hongjing Zang is a pioneering urologic surgeon whose work is reshaping the surgical management of penile cancer. Her primary research focuses on advanced surgical techniques, particularly the application of fluorescence-guided imaging to improve oncologic outcomes and reduce morbidity. Zang’s landmark contribution is her 2023 prospective, single-blind randomized controlled trial investigating indocyanine green (ICG) fluorescence-guided inguinal lymph node dissection (ILND). This study, already garnering 7 citations, directly addresses a critical challenge in penile cancer treatment: balancing the need for complete lymph node clearance with the high complication rates of traditional ILND. By demonstrating the safety and efficacy of ICG guidance, Zang has provided a compelling evidence base for a more precise, less invasive approach that could become a new standard of care. Her work not only advances surgical precision but also underscores her commitment to rigorous, patient-centered clinical research. For students and researchers, Zang exemplifies how a focused, high-impact clinical trial can translate a novel technique into tangible improvements in cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1